Sepragen.com

Home | Contact Us 


Online Catalog


View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at sales@sepragen.com.

 



All news items and press releases prior to 2008 are listed here. (Return to main News page.)

Press Release Archives

May 17, 2006: Sepragen Announces Intent to Acquire Assets of Cytobiologics and Pursue Development of Integrated Cell Culture/Purification System

May 15, 2006: Sepragen Announces Profibility and Doubling of Revenues for 2005; Announces New Financing Round

May 15, 2006: Sepragen Announces Biomedical Resources International, Inc. as New East Coast Representative

February 22, 2005: Sepragen Signs Supply Agreement with Pall Corporation for Bench-Top Chromatography Systems

December 9, 2002: Sepragen Reports Substantial Revenue Increase

June 5, 2002: Sepragen Announces the Launch of the QuantaSep 5000

July 10, 2001: Sepragen Plans Strategic Restructuring

January 15, 2001: Sepragen Announces Increased Bookings

January 12, 2001: Sepragen Relocates to New Facility

December 19, 2000: Sepragen Announces Senior Management Addition

November 27, 2000: Sepragen Announces Senior Management Addition

November 22, 2000: Sepragen Corporation Announces Third Quarter Results

November 16, 2000: Sepragen Announces Letter of Intent to Acquire Assets of Process Equipment, Inc.

August 9, 2000: Wedge - A Column Designed for Scale-Up Studies

July 11, 2000: Sepragen Corporation Announces The Addition of K. Charles Janac To Its Board of Directors.

April 5, 2000: Sepragen Corporation Completes $2.5 Million Private Stock Sale

March 27, 2000: Sepragen Corporation Announces Expiration Of Its Class A and Class B Redeemable Warrants

March 22, 2000: Sepragen Corporation Launches Quantasep 'BioTech Software' For Microsoft Windows NT

March 6, 2000: Sepragen Corporation Announces The Addition Of A “Techno-Business” Advisory Board

February 17, 2000: Sepragen Corporation Receives ‘Notice Of Allowance’ For Two Additional Patents

February 15, 2000: Sepragen Corporation Announces New Distributors For Its BioTech Business In Europe

February 7, 2000: Sepragen Corporation Announces The Addition Of Joseph R. Mallon, Jr. To Its Board Of Directors

September 24, 1999: Sepragen Corporation Announces Management Addition To Focus On Dairy Opportunities

September 21, 1999: Sepragen Corporation Announces Successful Commissioning Of Sepralac® Plant At Carbery Food Ingredients

September 3, 1999: Sepragen Corporation Announces Q2 Results; Losses Narrow

August 6, 1999: Sepragen Announces Successful Commercial Launch of Its Sepralac® Dairy Process at Anchor Products

July 23, 1999: Sepragen Announces Fiscal 1998 Year End Results and Fiscal 1999 First Quarter Results

March 4, 1999: Sepragen Converts Debt to Equity and Removes Lien on Patents

November 11, 1998: Sepragen Signs Pacific Rim Distributorship with YMC

October 15, 1998: Sepragen Announces Agreement With Carbery Food Ingredients

September 15, 1998: Sepragen Corporation Establishes Internet Presence

August 25, 1998: Sepragen Signs Major License Agreement With Dairy Leader, Anchor Products Ltd.

May 31, 1998: Sepragen Grants a Temporary License to Tropicana Products, Inc.

April 29, 1998: Sepragen Signs North American Distributorship with Bodman Industries

April 23, 1998: Sepragen Signs a Letter of Intent With GoldTech Ingredients Group

News Archives

May 11, 1999: Sepragen Corporation CEO discusses move from product development to commercialization, The Wall Street Transcript

March 1, 1999: Sepragen takes cutting edge off biotech products, American City Business Journal


Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2010 Sepragen Corporation. All rights reserved.